News
Autolus Therapeutics (AUTL) confirmed that the U.K. Medicines and Healthcare products Regulatory Agency has granted conditional marketing ...
The Global Virtual Care Market was valued at USD 7900 Million in 2023 and is anticipated to reach USD 24140 Million by 2030, witnessing a CAGR of 19.0% during the forecast period 2024-2030. Claim Your ...
Research from the University of Dundee has shown that training members of one of Scotland’s most marginalised groups to ...
A new strategy for tuberculosis (TB) screening, proposed by a team of researchers led by Queen Mary University of London, provides a solution to problems with current TB screening, which does not ...
BetGoodwin are a relatively new betting site that focus on horse racing. And it shows, because their racing-specific bonuses, ...
Japanese fashion retailer UNIQLO has opened its first regional store in Liverpool ONE. The casualwear titan launches with two ...
David Stancombe's daughter Elsie Dot Stancombe, seven, and Sergio Aguiar's girl Alice da Silva Aguiar, nine, were killed at a ...
Across the UK, modular buildings are reshaping how the NHS delivers care. With hospitals under pressure and patient numbers on the rise, there’s an urgent need for fast, flexible solutions that can ...
For help with dental emergencies outside normal opening hours – such as evenings, weekends, and public holidays, NHS 24 can be contacted on 111.
The parents of a baby left severely brain damaged by an NHS error have received a £35 million payout. The newborn was ...
Healthy adults without long-term conditions also exhibited higher smoking rates (24.6%). Publishing their findings in The ...
Pratteln, Switzerland, April 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results